Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
Company appoints five new independent directors to reconstituted board
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
Results consistent with previous trials, reinforcing benefit of Daiichi Sankyo and AstraZeneca’s ENHERTU in previously treated patients
Man lost 54 Kgs in 6 months with MGB procedure
Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
New deal strengthens Congenica’s presence in India
Subscribe To Our Newsletter & Stay Updated
